Type 2 Diabetes

Do added sugars and artificial sweeteners play an equal role in type 2 diabetes risk?

The evidence indicates resistant starches improve glucose metabolism beyond what would be expected from its reduced glycemic index.

We examine the results of various bariatric surgeries on long-term type 2 diabetes control and/or remission.

New research into distal pancreatectomies indicates that women and overweight patients have an elevated risk of suffering endocrine function impairment that leads to glucose intolerance and diabetes mellitus.

A new study turns conventional beliefs about metformin’s main site of action upside down.

New research on the link between diabetes and pancreatitis has shown a strong association between the severity of pancreatic dysfunction and subsequent risk of developing type 2 diabetes mellitus.

With a rallying cry of "Hands off Our Legs" protestors are due to picket the US Department of Health and Human Services over a proposed Medicare rule change that would affect amputees.

Finding more effective therapies for preventing diabetic nephropathy would be attractive, and a recent study has pointed to SGLT2 inhibitors as promising candidates in this area.

“In brief, the risk for T2DM is a combination of both person and place, and our national strategies need to understand and intervene across these levels.”

It may be cool to sip on a Coca-Cola that features your name right on the product, but a report that's been making the rounds details the metabolic roller coaster ride that drinking even a single can unleashes on the body.

Catch up on some of the latest headlines in diabetes care, including updates in pediatric management and an artificial pancreas.

What is the best way to treat a diabetic patient who has a metformin intolerance? Test your knowledge of alternative monotherapies, including SGLT2 inhibitors, GLP-1 agonists, and sulfonylureas.

There are pros and cons to using SGLT2 inhibitors in the elderly. Are you familiar with both? Find out with 7 quick multiple choice questions.

This slideshow presents several tips to keep in mind once ICD-10 goes live.

The Food and Drug Administration (FDA) issued a formal communication warning about the risk of acidosis with the use of SGLT2 inhibitors.

Data from two observational registries indicated that long-term testosterone replacement therapy in diabetic men was associated not only with better sexual function and weight loss, but also significant reductions in blood sugar.

Patients with diabetes may already be at increased risk for genital mycotic infections. We look at the likelihood of infection with SGLT2 inhibitors.

A considerable amount of progress has been made in treating diabetes this year both for type 1 and type 2 diabetes. The approval of new medications and potential devices in the future have made for a bright outlook for patients.

In previous studies, regular breakfast consumption has been correlated with lower BMI and improved cardiometabolic risk profile. Furthermore, evidence suggests that low-energy density, high-fiber, and high-carbohydrate foods may be more satiating when compared to their alternatives.

Although some studies have hinted at a possible role for metformin in pain management, a recent investigation found no difference in pain scores among diabetic patients who used metformin and those who did not

Researchers study whether or not GLP-1 affects pancreatic amylase or lipase plasma concentrations.

The Paleolithic (grain-free) diet is gathering steam among dieters and health conscious individuals alike. Proponents consume only items that, hypothetically, cavemen would have had access to. They claim that modern man can't metabolize comparatively new types of food, and our reliance on processed foods has increased rates of obesity, heart disease, and diabetes.

Test your knowledge of recent findings in SGLT2 inhibitor efficacy and safety research.

It can be difficult to determine which combinations of antihyperglycemic medications might work best, and for which patients. A recent review investigates combined therapy, with a focus on the newer DPP-4 and SGLT2 inhibitors.